KeyBanc Reiterates Overweight Rating on Evolent Health (EVH)
Tweet Send to a Friend
KeyBanc analyst Matthew Gillmor reiterated an Overweight rating and $20.00 price target on Evolent Health (NYSE: EVH).The analyst commented: "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
